Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 7, 2018
TherapeuticsMD to Present at Two Upcoming Investor Conferences
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced that the Company will participate in the Cowen and Company 38th Annual ...
March 7, 2018
STRATA Skin Sciences, Inc. Delays Fourth Quarter and Fiscal 2017 Financial Results
HORSHAM, Pa., March 06, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to ...
March 7, 2018
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology
SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics that target the underlying ...
March 7, 2018
BioDelivery Sciences to Host Conference Call and Webcast Reporting Fourth Quarter and Full-Year 2017 Financial Results on Thursday, March 15
RALEIGH, N.C., March 07, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
March 7, 2018
Catalyst Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 7, 2018
Aimmune Therapeutics to Participate in Four Investor Conferences in March
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced that members of the Aimmune executive management team ...
March 7, 2018
BioCanCell Announces Two New Key Hires in Clinical Development and Clinical Operations
CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE:BICL), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies ...
March 7, 2018
BioTime Announces DSMB Approval to Proceed to Cohort 4 of the OpRegen® Clinical Trial
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, today announced that the independent Data Safety Monitoring Board ...
March 7, 2018
UroGen to Present at March 2018 Investor Conferences
RA’ANANA, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN) today announced that management plans to present at two investor ...
March 7, 2018
Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio
Copenhagen, March 7, 2018 - Zealand Pharma A/S ("Zealand") (CVR No. 20 04 50 78) announces financial results in line with guidance and considerable progress ...
March 7, 2018
INVENTIVA : 2017 Full Year Results - Major progress achieved in clinical development and strong cash position
Daix (France), March 7, 2018 - Inventiva, a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) and mucopolysaccharidosis (MPS), today reported ...
March 6, 2018
Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
March 6, 2018
Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors
HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
March 6, 2018
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana
Basel, Switzerland, March 06, 2018 - Basilea Pharmaceutica Ltd. (BSLN.SW) announced today that partner Grupo Biotoscana S.L. ("GBT") has launched Basilea`s hospital antibiotic Zevtera® (ceftobiprole) ...
March 6, 2018
Aptose to Participate in Upcoming Investor Conferences In March 2018
SAN DIEGO and TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
March 6, 2018
Arrowhead to Present at Barclays Global Healthcare Conference 2018
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (ARWR) today announced that the company will make a presentation at the following upcoming event: Barclays Global Healthcare Conference – ...
March 6, 2018
Foamix Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference
REHOVOT, Israel, and BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing ...
March 6, 2018
Eiger BioPharmaceuticals to Participate in U.S. and International Investor and Partnership Conferences in March
PALO ALTO, Calif., March 6, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
March 6, 2018
Altimmune to Participate at Two Investor Conferences in March
GAITHERSBURG, Md., March 06, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, ...
March 6, 2018
CymaBay to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Thursday, March 15
NEWARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
Page 60 of 117